课题基金 / 基金详情

New Chemical Tools for the Synthesis of Trisubstituted Hydroxylamines and their Application as Bioisosteres in Medicinal Chemistry

New Chemical Tools for the Synthesis of Trisubstituted Hydroxylamines and their Application as Bioisosteres in Medicinal Chemistry
合成三取代羟胺的新化学工具及其在药物化学中作为生物等排体的应用
批准号:
10349762
负责人:
David Crich
金额:
$22.32万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-09-15 至 2023-08-31

项目摘要

项目成果

David Crich的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This is a proposal to develop new tools for the practical effective synthesis of N,N,O- trisubstituted hydroxylamines, or hydroxalogs, as novel isosteres for application in medicinal chemistry across a broad swath of compound classes and diseases states. The three specific aims presented encompass i) tools development for the synthesis of N,N,O-trisubstituted hydroxylamines by a variety of inter- and intramolecular methods; ii) synthesis of a series of phenylpropylpiperidine ligands for the σ-1 and σ-2 receptors and their use as models for the comparative study of the physical and drug-like properties of the hydroxalogs, thereby enhancing their applicability as tools in medicinal chemistry; iii) synthesis of a series of hydroxalogs of the ethanolamine H1 antagonists and comparative determination of their antihistamine activity in a cell-based assay, again with the view to validating the hydroxalogs as isosteres as tools in medicinal chemistry.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Photochemical Technologies for Improved Glycosylation Reactions
  • 批准号:
    10627108
  • 项目类别:
  • 资助金额:
    $21.74万
  • 财政年份:
    2023
  • 负责人:
    David Crich
  • 依托单位:
Shaping Next Generation Aminoglycoside Antibiotics for Treatment of Multidrug-Resistant Diseases
  • 批准号:
    10585038
  • 项目类别:
  • 资助金额:
    $65.47万
  • 财政年份:
    2023
  • 负责人:
    David Crich
  • 依托单位:
Evaluation of Streptamine Analogs to Overcome Resistance to Apramycin
  • 批准号:
    10557532
  • 项目类别:
  • 资助金额:
    $19.13万
  • 财政年份:
    2022
  • 负责人:
    David Crich
  • 依托单位:
Shaping Next Generation Aminoglycoside Antibiotics for Treatment of Multidrug- Resistant Diseases
  • 批准号:
    9934590
  • 项目类别:
  • 资助金额:
    $59.74万
  • 财政年份:
    2019
  • 负责人:
    David Crich
  • 依托单位:
海外基金